Targeting protein kinases for tumor therapy

被引:21
作者
Sachsenmaier, C [1 ]
机构
[1] KTB Tumorforsch Gesell mbH, Kin Tumorbiol, D-79106 Freiburg, Germany
来源
ONKOLOGIE | 2001年 / 24卷 / 04期
关键词
protein kinases; receptor tyrosine kinases; serine/threonine kinases; targets; tumor therapy; clinical trials; inhibitors;
D O I
10.1159/000055106
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Phosphorylation is the most common biochemical modification of cellular molecules, regulating fundamental cellular processes like growth, differentiation, proliferation, movement, and death. It is now clear that protein and lipid kinases as well as phosphatases are causally involved in human disease, especially in cancer. The first part of this review tries to compile our current knowledge about the involvement of protein kinases in human cancer. Phosphatases as well as phospholipid kinases will be omitted from this article for the purpose of simplification. In the second part an updated list of ongoing clinical trials involving protein kinases as targets for tumor therapy will be given, together with a brief summary of technical approaches in targeting protein kinases for therapy.
引用
收藏
页码:346 / 355
页数:12
相关论文
共 137 条
[1]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[2]   High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein [J].
Amemiya, H ;
Kono, K ;
Mori, Y ;
Takahashi, A ;
Ichihara, F ;
Iizuka, H ;
Sekikawa, T .
ONCOLOGY, 2000, 59 (02) :145-151
[3]   Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin [J].
Baselga, J ;
Pfister, D ;
Cooper, MR ;
Cohen, R ;
Burtness, B ;
Bos, M ;
D'Andrea, G ;
Seidman, A ;
Norton, L ;
Gunnett, K ;
Falcey, J ;
Anderson, V ;
Waksal, H ;
Mendelsohn, J .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :904-914
[4]   Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation [J].
Baskaran, R ;
Wood, LD ;
Whitaker, LL ;
Canman, CE ;
Morgan, SE ;
Xu, Y ;
Barlow, C ;
Baltimore, D ;
WynshawBoris, A ;
Kastan, MB ;
Wang, JYJ .
NATURE, 1997, 387 (6632) :516-519
[5]   THE 1ST INTRON IN THE HUMAN C-ABL GENE IS AT LEAST 200 KILOBASES LONG AND IS A TARGET FOR TRANSLOCATIONS IN CHRONIC MYELOGENOUS LEUKEMIA [J].
BERNARDS, A ;
RUBIN, CM ;
WESTBROOK, CA ;
PASKIND, M ;
BALTIMORE, D .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (09) :3231-3236
[6]   A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers [J].
Bischoff, JR ;
Anderson, L ;
Zhu, YF ;
Mossie, K ;
Ng, L ;
Souza, B ;
Schryver, B ;
Flanagan, P ;
Clairvoyant, F ;
Ginther, C ;
Chan, CSM ;
Novotny, M ;
Slamon, DJ ;
Plowman, GD .
EMBO JOURNAL, 1998, 17 (11) :3052-3065
[7]  
BONGARZONE I, 1989, ONCOGENE, V4, P1457
[8]  
BONGARZONE I, 1994, CANCER RES, V54, P2979
[9]  
Burrow S, 1998, J SURG ONCOL, V69, P21, DOI 10.1002/(SICI)1096-9098(199809)69:1<21::AID-JSO5>3.0.CO
[10]  
2-M